Fundamental Analysis of VENUS CONCEPT INC(NASDAQ:VERO) stock

Fundamental Rating

Overall VERO gets a fundamental rating of 2 out of 10. We evaluated VERO against 192 industry peers in the Health Care Equipment & Supplies industry. VERO may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, VERO is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year VERO has reported negative net income.

In the past year VERO has reported a negative cash flow from operations.

In the past 5 years VERO always reported negative net income.

VERO had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

VERO has a Return On Assets of -39.78%. This is in the lower half of the industry: VERO underperforms 61.98% of its industry peers.

		Industry Rank	Sector Rank
ROA	-39.78%
ROE	N/A
ROIC	N/A

ROA(3y)-29.74%

ROA(5y)-32.73%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

VERO has a better Gross Margin (68.32%) than 76.04% of its industry peers.

In the last couple of years the Gross Margin of VERO has grown nicely.

The Profit Margin and Operating Margin are not available for VERO so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	68.32%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.21%

GM growth 5Y9.61%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

VERO does not have a ROIC to compare to the WACC, probably because it is not profitable.

VERO has more shares outstanding than it did 1 year ago.

VERO has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, VERO has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -3.62, we must say that VERO is in the distress zone and has some risk of bankruptcy.

The Altman-Z score of VERO (-3.62) is worse than 68.23% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-3.62

ROIC/WACCN/A

WACC5.16%

2.3 Liquidity

VERO has a Current Ratio of 2.13. This indicates that VERO is financially healthy and has no problem in meeting its short term obligations.

VERO has a worse Current ratio (2.13) than 71.88% of its industry peers.

VERO has a Quick Ratio of 1.39. This is a normal value and indicates that VERO is financially healthy and should not expect problems in meeting its short term obligations.

VERO has a Quick ratio of 1.39. This is in the lower half of the industry: VERO underperforms 71.88% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.13
Quick Ratio	1.39

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

VERO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.74%, which is quite impressive.

VERO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -23.26%.

The Revenue has been growing by 28.26% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)29.74%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q4.29%

Revenue 1Y (TTM)-23.26%

Revenue growth 3Y-0.71%

Revenue growth 5Y28.26%

Revenue growth Q2Q-25.35%

3.2 Future

VERO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.25% yearly.

Based on estimates for the next years, VERO will show a decrease in Revenue. The Revenue will decrease by -0.77% on average per year.

EPS Next Y29.8%

EPS Next 2Y32.25%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-10.16%

Revenue Next 2Y-0.77%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VERO. In the last year negative earnings were reported.

Also next year VERO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

VERO's earnings are expected to grow with 32.25% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y32.25%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

VERO does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

VENUS CONCEPT INC

NASDAQ:VERO (4/29/2024, 7:00:03 PM)

0.6501

-0.03 (-5%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap4.13M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-39.78%
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	68.32%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.82

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	2.13
Quick Ratio	1.39
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)29.74%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y29.8%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-23.26%

Revenue growth 3Y-0.71%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

VENUS CONCEPT INC (VERO)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens